
    
      Obtain real world, post market data to confirm the clinical improvement and safety in
      patients treated with a single injection of MONOVISC for the symptomatic relief of
      osteoarthritis in the ankle joint. The entire study duration from first subject in to last
      subject out will be approximately one and half years. The enrollment phase will be
      approximately 12 months with a follow-up phase of 6 months. Visits will be scheduled at
      screening, baseline, 1 month, 3 months and 6 months post treatment.
    
  